MedTrace Logo

Jacobson's Progressive Muscle Relaxation Technique With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive Individuals

NCT06997445 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-09-15

No results posted yet for this study

Summary

The study is a randomized controlled trial. The purpose of study is to compare the additive effects of Jacobson's progressive muscle relaxation technique with aerobic exercise versus aerobic exercise on cardiopulmonary parameters including systolic and diastolic blood pressure, heart rate, respiratory rate, rate pressure product and quality of life in stage 1 hypertensive individuals.

Conditions

Interventions

OTHER

Interventional group: Jacobson's progressive muscle relaxation technique with aerobic exercise

Jacobaon's progressive muscle relaxation technique for 15 minutes Total duration: 45 minutes

OTHER

Aerobic Exercise

Participants in this group will only be provided aerobic exercise for 4 weeks supervised by physiotherapist. Aerobic Exercise include the following: * Warm up exercises for 5 minutes. * Brisk walking on treadmill for 25 minutes which include warm up period for 10 minutes then 14 minutes brisk walk and cool down period included 1 minute walk. * Stepper for 5 minutes. * Static cycling for 5 minutes. * Cool down for 5 minutes. Week 03 and Week 04: Frequency: 5 days per week Intensity: 60-80% Target heart rate Time: 45 minutes Week 01 and Week 02: Frequency: 5 days per week Intensity: 50-60 % Target heart rate Time: 45 minutes

Sponsors & Collaborators

  • Foundation University Islamabad

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-02
Primary Completion
2025-06-05
Completion
2025-06-05

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06997445 on ClinicalTrials.gov